
Stocks Stage A Reversal.. And The Latest Health Care M&A 11/14/25
CNBC's "Fast Money"
00:00
Pharma M&A: Merck Acquires Sidera Therapeutics
Melissa Lee and Jared Holtz discuss Merck's $9.2B Sidera deal, pipeline urgency ahead of Keytruda's patent expiry, and valuation context.
Play episode from 29:00
Transcript


